Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Urologix Inc

ULGX
Current price
0.0001 USD 0 USD (0.00%)
Last closed 0.0001 USD
ISIN US9172731047
Sector Healthcare
Industry Medical Devices
Exchange PINK
Capitalization 82 907 USD
Yield for 12 month 0.00 %
1Y
3Y
5Y
10Y
15Y
ULGX
21.11.2021 - 28.11.2021

Urologix, Inc. develops, manufactures, markets, and distributes minimally invasive medical products for the treatment of obstruction and symptoms due to benign prostatic hyperplasia (BPH) in the United States. The company offers Cooled ThermoTherapy, which produces targeted microwave energy combined with a cooling mechanism to protect healthy tissue and enhance patient comfort. It also provides Prostiva RF Therapy System that delivers radio frequency energy directly into the prostate to destroy prostate tissue, reduce constriction of the urethra, and relieve BPH symptoms. It serves patients and clinicians. Urologix, Inc. was founded in 1991 and is based in Minneapolis, Minnesota. Address: 14405 21st Avenue North, Minneapolis, MN, United States, 55447

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

1.5 USD

P/E ratio

Dividend Yield

Current Year

+14 235 000 USD

Last Year

+16 590 000 USD

Current Quarter

+2 796 000 USD

Last Quarter

+3 079 000 USD

Current Year

+6 093 000 USD

Last Year

+8 183 000 USD

Current Quarter

+1 311 000 USD

Last Quarter

+1 464 000 USD

Key Figures ULGX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -373 000 USD
Operating Margin TTM -5.56 %
PE Ratio
Return On Assets TTM -7.62 %
PEG Ratio
Return On Equity TTM
Wall Street Target Price 1.5 USD
Revenue TTM 11 999 000 USD
Book Value -0.38 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -16.7 %
Dividend Yield
Gross Profit TTM 5 896 000 USD
Earnings per share -0.01 USD
Diluted Eps TTM -0.01 USD
Most Recent Quarter I 2015
Quarterly Earnings Growth YOY
Profit Margin -38.9 %

Dividend Analytics ULGX

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History ULGX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation ULGX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 0.4038
Price Sales TTM 0.0069
Enterprise Value EBITDA -9.5221
Price Book MRQ

Financials ULGX

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators ULGX

For 52 weeks

0.0001 USD 0.0001 USD
50 Day MA 0.0001 USD
Shares Short Prior Month 40 942
200 Day MA 0.0001 USD
Short Ratio 1.02
Shares Short 41 225
Short Percent 0.3 %